| Aldis Peteris Siltumens, MD | |
|
1000 N Oak Ave, Marshfield, WI 54449-5703 | |
| (715) 387-5511 | |
| Not Available |
| Full Name | Aldis Peteris Siltumens |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 7 Years |
| Location | 1000 N Oak Ave, Marshfield, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235660465 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 64555 (Minnesota) | Secondary |
| 207L00000X | Anesthesiology | 76791 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marshfield Medical Center | Marshfield, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mchs Hospitals Inc | 5698071173 | 1049 |
News Archive
Cellectis, the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide right to use inventions related to TAL effector-mediated DNA recognition and cleavage. This revolutionary approach for the targeted modification of genomes was developed by the University of Minnesota and Iowa State University.
The Boston Globe: Despite being home to the largest number of doctors per person, finding a primary care physician has been getting more difficult for Massachusetts residents since 2006, according a report released by the state. "Last year 60 percent of family-medicine doctors' offices were accepting new patients, down from 70 percent in 2007, the first full year after the state mandated near-universal health insurance coverage. Last year only 44 percent of internal medicine practices were accepting new patients, down from 66 percent in 2005.
Men who carry a faulty version of the BRCA2 gene have an estimated one-in-15 chance of developing breast cancer by the time they reach 70, British scientists have found.
Swimming is one of the best forms of exercise. It's easy on the joints and provides a terrific workout in terms of aerobic exercise and improving muscle strength.
Bayer HealthCare and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.
› Verified 2 days ago
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
Cellectis, the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide right to use inventions related to TAL effector-mediated DNA recognition and cleavage. This revolutionary approach for the targeted modification of genomes was developed by the University of Minnesota and Iowa State University.
The Boston Globe: Despite being home to the largest number of doctors per person, finding a primary care physician has been getting more difficult for Massachusetts residents since 2006, according a report released by the state. "Last year 60 percent of family-medicine doctors' offices were accepting new patients, down from 70 percent in 2007, the first full year after the state mandated near-universal health insurance coverage. Last year only 44 percent of internal medicine practices were accepting new patients, down from 66 percent in 2005.
Men who carry a faulty version of the BRCA2 gene have an estimated one-in-15 chance of developing breast cancer by the time they reach 70, British scientists have found.
Swimming is one of the best forms of exercise. It's easy on the joints and provides a terrific workout in terms of aerobic exercise and improving muscle strength.
Bayer HealthCare and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System-franciscan Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629056049 PECOS PAC ID: 0345152443 Enrollment ID: O20031110000684 |
News Archive
Cellectis, the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide right to use inventions related to TAL effector-mediated DNA recognition and cleavage. This revolutionary approach for the targeted modification of genomes was developed by the University of Minnesota and Iowa State University.
The Boston Globe: Despite being home to the largest number of doctors per person, finding a primary care physician has been getting more difficult for Massachusetts residents since 2006, according a report released by the state. "Last year 60 percent of family-medicine doctors' offices were accepting new patients, down from 70 percent in 2007, the first full year after the state mandated near-universal health insurance coverage. Last year only 44 percent of internal medicine practices were accepting new patients, down from 66 percent in 2005.
Men who carry a faulty version of the BRCA2 gene have an estimated one-in-15 chance of developing breast cancer by the time they reach 70, British scientists have found.
Swimming is one of the best forms of exercise. It's easy on the joints and provides a terrific workout in terms of aerobic exercise and improving muscle strength.
Bayer HealthCare and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.
› Verified 2 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
Cellectis, the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide right to use inventions related to TAL effector-mediated DNA recognition and cleavage. This revolutionary approach for the targeted modification of genomes was developed by the University of Minnesota and Iowa State University.
The Boston Globe: Despite being home to the largest number of doctors per person, finding a primary care physician has been getting more difficult for Massachusetts residents since 2006, according a report released by the state. "Last year 60 percent of family-medicine doctors' offices were accepting new patients, down from 70 percent in 2007, the first full year after the state mandated near-universal health insurance coverage. Last year only 44 percent of internal medicine practices were accepting new patients, down from 66 percent in 2005.
Men who carry a faulty version of the BRCA2 gene have an estimated one-in-15 chance of developing breast cancer by the time they reach 70, British scientists have found.
Swimming is one of the best forms of exercise. It's easy on the joints and provides a terrific workout in terms of aerobic exercise and improving muscle strength.
Bayer HealthCare and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aldis Peteris Siltumens, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (715) 387-5511 | Aldis Peteris Siltumens, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (715) 387-5511 |
News Archive
Cellectis, the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide right to use inventions related to TAL effector-mediated DNA recognition and cleavage. This revolutionary approach for the targeted modification of genomes was developed by the University of Minnesota and Iowa State University.
The Boston Globe: Despite being home to the largest number of doctors per person, finding a primary care physician has been getting more difficult for Massachusetts residents since 2006, according a report released by the state. "Last year 60 percent of family-medicine doctors' offices were accepting new patients, down from 70 percent in 2007, the first full year after the state mandated near-universal health insurance coverage. Last year only 44 percent of internal medicine practices were accepting new patients, down from 66 percent in 2005.
Men who carry a faulty version of the BRCA2 gene have an estimated one-in-15 chance of developing breast cancer by the time they reach 70, British scientists have found.
Swimming is one of the best forms of exercise. It's easy on the joints and provides a terrific workout in terms of aerobic exercise and improving muscle strength.
Bayer HealthCare and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.
› Verified 2 days ago
Ned G Nordin, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-7179 | |
Dr. Roman Krasnov, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 570-271-6211 | |
Dr. Brennan Reece Harding, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 | |
Muhammad Ubaidulhaq, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 | |
Charles P Strachan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-7179 | |
Aby Dixon Pynadath, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 |